As with all health care costs, Medicare out-of-pocket costs are rising rapidly. In 2022, Medicare...
Drugs and technology
2021: Medicare drug price negotiation appears a long shot
It has been 32 years since Senator David Pryor, then Chair of the Senate Aging Committee made the...
Daily use of baby aspirin can present greater risks than benefits
For quite some time now, older adults with certain health conditions have been told to take a daily...
MedPac: High drug prices mean higher Medicare spending
Not only are drug prices rising at the pharmacy for people with Medicare, but drug prices are...
Increase in antibiotic resistance affecting older adults
A new study in Clinical Infectious Diseases finds that an increase in antibiotic resistance is...
US is a goldmine for pharmaceutical companies
Public Citizen released a report illustrating how the US is a goldmine for pharmaceutical...
Coronavirus: Should you get the Pfizer booster vaccine?
The FDA gave emergency approval to Pfizer’s “booster” vaccine for people over 65...
Merck charged with blocking generic competition
Paige Minemeyer reports for FierceHealthcare on a lawsuit filed by two insurers against Merck for...
Our drug supply needs an overhaul
Farah Stockman writes an opinion piece for The New York Times on our “sick” drug supply...
Budget reconciliation: What’s happening with drug prices?
As the Democrats in Congress work on the budget reconciliation bill, a lot is happening with drug...